|
Volumn 290, Issue 5493, 2000, Pages 989-992
|
Role of BAX in the apoptotic response to anticancer agents
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
INDOMETACIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROTEIN BAX;
PROTEIN BCL X;
SULINDAC;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CHEMOPROPHYLAXIS;
DRUG EFFECT;
DRUG TARGETING;
GENE MUTATION;
GENOTYPE;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTICARCINOGENIC AGENTS;
ANTIMETABOLITES, ANTINEOPLASTIC;
APOPTOSIS;
BCL-2-ASSOCIATED X PROTEIN;
BCL-X PROTEIN;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
GENES, P53;
HUMANS;
INDOMETHACIN;
INTRACELLULAR MEMBRANES;
MEMBRANE POTENTIALS;
MITOCHONDRIA;
MUTATION;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PROTO-ONCOGENES;
SULINDAC;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0034602188
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.290.5493.989 Document Type: Article |
Times cited : (808)
|
References (28)
|